It was the second downgrade in a matter of weeks for the three-hospital system after Fitch lowered its rating from “CCC+” to “CCC” Sept. 19.
“The downgrade reflects Tower Health’s significant ongoing operating losses, albeit at a lower level, that are expected to continue in fiscal 2024, and a steep decline in unrestricted reserves to a level that we view as highly vulnerable,” said S&P Global Ratings credit analyst Anne Cosgrove.
There could be a further downgrade for Tower Health given the system’s negative outlook, S&P said, assessing a 1 in 3 chance of such a downgrade happening.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
